NCT01181167View on ClinicalTrials.gov

A Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty

PHASE3CompletedINTERVENTIONAL
Enrollment

610

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

January 31, 2010

Study Completion Date

March 31, 2010

Conditions
PreventionVenous Thromboembolism
Interventions
DRUG

edoxaban

DRUG

enoxaparin sodium

Trial Locations (2)

Unknown

Osaka

Tokyo

Sponsors
All Listed Sponsors
lead

Daiichi Sankyo Co., Ltd.

INDUSTRY

NCT01181167 - A Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty | Biotech Hunter | Biotech Hunter